Major Subtypes of NSCLC
Watch
Changing Melanoma Treatment in 2017
Omid A. Hamid, M.D., of The Angeles Clinic and Research Institute and Jason J. Luke, M.D., of University of Chicago Medicine, share treatment approaches on the horizon for patients with melanoma.
The Concept and Reality of Precision Medicine
The Essentials of Nutrition and Digestive Health in Pancreatic Cancer
Liver Cancer: What's On the Horizon?
The Unmet Needs of Patients with GI Cancer
A Stronger, More Unified Voice to Fight GI Cancers
Promise in Pancreatic Cancer
Make a Difference Today for Someone Fighting for Their Tomorrow
NFL Hall of Famer Jim Kelly discusses what inspires him to continue fighting for patients with cancer.
Jim Kelly Discusses His Cancer Diagnosis
NFL Hall of Famer Jim Kelly discusses his thoughts when he was diagnosed with neck squamous cell carcinoma in his upper jaw.
Ovarian Cancer: Enrolling in Clinical Trials
Therapeutic Approaches for Ovarian Cancer
The Role of BRCA Testing in Ovarian Cancer
Andrew Schorr on How Journalism Led Him to Patient Advocacy
Andrew Schorr, founder of Patient Power and Patient Empowerment and 2016 MPN Hero, discusses how his background in journalism led him to patient advocacy.
What's Exciting in the Field of MPNs?
Ross L. Levine, M.D., physician-scientist, director of the Memorial Sloan Kettering (MSK) Center for Hematologic Malignancies and 2016 MPN Hero, discusses the work at his lab that he is currently excited about.
Elliott Winton on the Changing Landscape of MPN Treatment
Elliott Winton, M.D., researcher, physician and 2016 MPN Hero, discusses some of the drastic changes that happened over the past decade or so in the world of MPNs.
Patricia K. Koenig: Living With Polycythemia Vera
Patricia K. Koenig, patient advocate and 2016 MPN Hero, discusses living with polycythemia vera (PV).
Using Social Media to Recruit for Cancer Clinical Trials
Alicia Staley, survivor and patient advocacy manager of Cure Forward, discusses the potential use of social media to recruit for clinical trials for new cancer treatment.
MM4MM 2017 Kilimanjaro Team Training Climb
This year, a group of patients, advocates and health care professionals will tackle Mount Kilimanjaro to raise money and awareness for multiple myeloma.
Miracles Do Happen in GBM
Dellann Elliott Mydland, founder and president of the EndBrainCancer Initiative and 2016 GBM Hero, discusses how miracles do happen in the world of glioblastoma multiforme (GBM), and people survive.
Educating Patients to Ensure the Best MPN Care
Erin H. Blackwell, R.N., B.S.N., O.C.N., oncology nurse and 2016 MPN Hero, discusses what to discuss with newly diagnosed patients with MPNs to ensure the best possible care.
Bonnie J. Blankert on Being a Caregiver to Someone With an MPN
Bonnie Joyce Blankert, caregiver and 2016 MPN Hero, discusses the importance of remaining calm when caregiving for a loved one with MPN who recently had a stem cell transplant.
Sam Smith Explains Cognitive Behavioral Therapy for Patients With Breast Cancer
Sam Smith, University of Leeds, explains cognitive behavioral therapy for patients with breast cancer.
David Wallace on Being Your Own Cancer Advocate
After being diagnosed with polycythemia vera, David Wallace, who publishes PV Reporter and MPN Cancer Connection, quickly learned that he must be his own advocate.
Gary Mervis on Putting Cancer on the "Front Burner"
Gary Mervis, 2016 GBM Hero and founder of Camp Good Days and Special times, Inc., discusses the need for research in the field of glioblastoma multiforme (GBM).
Ann Brazeau on the Importance of MPN Support Groups
Ann Brazeau, founder and CEO of MPN Advocacy & Education International and a 2016 MPN Hero, discusses the importance and benefits of MPN support groups.
Sumul Raval Tells Patients With GBM, "I'm Your Quarterback"
Sumul N. Raval, M.D., founder and director of the Zocchi Brain Tumor Center at Monmouth Medical Center and 2016 GBM hero, tells his patients, "I'm your quarterback."
Siddhartha Mukherjee on Increasing MPN Awareness
Siddhartha Mukherjee, M.D., Ph.D, an oncologist, researcher and Pulitzer Prize-winning science writer, discusses the increasing awareness about myeloproliferative neoplasms (MPNs).
What's Next in Immunotherapy?
Melanoma should not be considered to be in a "special category" that responds well to immunotherapy, according to Christian M. Capitini, M.D., assistant professor of Pediatrics at the University of Wisconsin.
Personalized Cancer Care Plans in the Age of "Dr. Google"
Ann Culkin, R.N., O.C.N, an oncology nurse at Memorial Sloan Kettering Cancer Center, discusses the importance of patient-centered care in the age of the internet.